APA (7th ed.) Citation

Y, D., C, G., R, S., F, D., B, S., B, D., . . . D, B. (2026). Efficacy and safety of steroid-sparing strategy in the treatment of AIHA associated with KSHV/HHV-8 positive multicentric Castleman disease. HemaSphere, 10(4), e70304. https://doi.org/10.1002/hem3.70304

Chicago Style (17th ed.) Citation

Y, Dieudonné, et al. "Efficacy and Safety of Steroid-sparing Strategy in the Treatment of AIHA Associated with KSHV/HHV-8 Positive Multicentric Castleman Disease." HemaSphere 10, no. 4 (2026): e70304. https://doi.org/10.1002/hem3.70304.

MLA (9th ed.) Citation

Y, Dieudonné, et al. "Efficacy and Safety of Steroid-sparing Strategy in the Treatment of AIHA Associated with KSHV/HHV-8 Positive Multicentric Castleman Disease." HemaSphere, vol. 10, no. 4, 2026, p. e70304, https://doi.org/10.1002/hem3.70304.